SCHNEIDER EUGENE (EVP, Chf Clinical Develop Offc) sold 8.1% of their position (6.18K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $515.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/2/2026ACC: 0000874015-26-000101
Officer· EVP, Chf Clinical Develop Offc
Since Dec 2020
+5.81K
Net shares
Net buyer
$515.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
11.99K acquired · 6.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.99K
Price / share
—
Trade value
—
% of position
18.8%
1/29/2026
63.89K→75.88K
Common Stock
Direct
Shares
−6.18K
Price / share
$83.45
Trade value
$515.63K
% of position
8.1%
1/30/2026
75.88K→69.70K
Total
Net shares
+5.81K
Net value
-$515.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2026 | A · Award | +11.99K | — | — | 18.8% | 63.89K | 75.88K |
| Common Stock Direct | 1/30/2026 | S · Sale | −6.18K | $83.45 | $515.63K | 8.1% | 75.88K | 69.70K |
| Total | +5.81K | -$515.63K | ||||||
Derivative Transactions0
No derivative transactions reported